You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CBIO Sale Disclosure
Brumm Joshua T · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$130.96K
Brumm Joshua T Chief Executive Officer
CBIO
Transaction date
Sep 18, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed same day
CBIO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 7,837 shares @ $16.71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-062701
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$159.78K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crescent Biopharma, Inc. CBIO Current | Sale | Sep 18, 2026 | $130.96K |
| Crescent Biopharma, Inc. CBIO | Sale | Sep 16, 2026 | $28.82K |